Simulation training as a response to the demand of critical patients COVID19: safety and quality of care

Main Article Content

Luís Manuel Mota de Souza
https://orcid.org/0000-0002-9708-5690
Maria do Céu Mendes Pinto Marques

Abstract

Coronavirus Disease (COVID-19), also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first described in December 2019 in Wuhan, China. It has spread across all continents and was declared by the World Health Organization (WHO), on March 11, 2020, as a global pandemic. On June 24, 2020, 9,129,146 cases and 473,797 deaths from SARS-CoV-2 / COVID 19 were reported by the WHO. The virus is transmitted through droplets, although it has also been found in feces and blood, thus allowing other means of potential transmission. The symptoms associated with SARS-CoV -2 infection include fever, myalgia or fatigue, productive cough or non-productive cough dyspnoea, fatigue, or myalgia in most cases. There are also reports of symptoms such as headache, sore throat, hemoptysis and gastrointestinal symptoms such as diarrhea, nausea and abdominal pain, but with less incidence.


 



Article Details

How to Cite
1.
Souza LMM de, Marques M do CMP. Simulation training as a response to the demand of critical patients COVID19: safety and quality of care. HSJ [Internet]. 2020 Jun. 30 [cited 2024 Nov. 22];10(3):3-4. Available from: https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1009
Section
EDITORIAL
Author Biographies

Luís Manuel Mota de Souza, Universidade de Évora, Évora. Portugal.

Comprehensive Health Research Centre (CHRC), Departamento de Enfermagem da Universidade de Évora, Évora, Portugal.

Maria do Céu Mendes Pinto Marques, Universidade de Évora, Évora, Portugal.

Comprehensive Health Research Centre (CHRC), Departamento de Enfermagem da Universidade de Évora, Évora, Portugal

References

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. doi: 10.1001/jama.2020.1585.

World Health Organization (2020a) [Internet]. Coronavirus disease 2019 (COVID-19) Situation report – 156 [cited 2020 Jun 25]. Avaiable from: www.who.int/docs/default-source/coronaviruse/situation-reports/20200624-covid-19-sitrep-156.pdf?sfvrsn=af42e480_2

Del Rio C, Malani PN. COVID-19 — new insights on a rapidly changing epidemic. JAMA. 2020;323(14):1339-40. doi: 10.1001/jama.2020.3072

Ziehr DR, Alladina J, Petri CR, Maley JH, Moskowitz A, Medoff BD, et al. Respiratory pathophysiology of mechanically ventilated patients with COVID-19: a cohort study. Am J Respir Crit Care Med. 2020; 201(12):1560-4. doi: 10.1164/rccm.202004-1163LE

Möhlenkamp S, Thiele H. Ventilation of COVID-19 patients in intensive care units. Herz. 2020;45:329-31. doi: 10.1007/s00059-020-04923-1

Liu Y, Yan LM, Wan L, Xiang TX, Le A, Liu JM, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;20(6):656-7. doi: 10.1016/S1473-3099(20)30232-2

Lopez RA, Anthony A, Zuo L, Enomoto TM, Aziz MF. Your COVID-19 intubation kit. Anesth Analg. 2020;131(1):e28-30. doi: 10.1213/ANE.0000000000004855

Muret-Wagstaff SL, Collins JS, Mashman DL, Patel SG, Pettorini K, Rosen SA, et al. In situ simulation enables operating room agility in the COVID-19 pandemic. Ann Surg. 2020 [published 2020 May 20]. [Epub ahead of print]. doi: 10.1097/SLA.0000000000004056

Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med. 2020;8(5):518-26. doi: 10.1016/S2213-2600(20)30121-1

Fregene TE, Nadarajah P, Buckley JF, Bigham S, Nangalia V. Use of in situ simulation to evaluate the operational readiness of a high‐consequence infectious disease intensive care unit. Anaesth. 2020;75(6):733-8. doi: 10.1111/anae.15048